MEPSGEN attended the 2024 BIO KOREA International Convention on May 8th to 10th in Seoul, South Korea.

BioKorea is an event organized since 2006 to promote the global status and sustainable growth of Korea's healthcare industry, 

and was held for the 19th time in 2024.

The 19th BIO KOREA had successfully organized various programs including Business Partnering, Exhibition, Invest Fair, and Conference, under theme of “The Future of Biotechnology Innovation and Global Collaboration” to facilitate the sharing of cutting-edge technologies among entrepreneurs, researchers, and experts in the bio-health industry.

At the exhibition, MEPSGEN showcased the MEPS-X series. In particular, the MEPS-ORD chip that can implement organoids was newly exhibited, and the newly released ProMEPS™ and Nanocalibur™ were also introduced.

ProMEPS™ is the robotic automation for all-in-one processing of microphysiological system modeling, and Nanoclaibur is the scalable nanoparticle synthesis system that will be launched in July. Both system received strong interest from visitors, and consultations on the systems were active.